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Edited by Gianni CesareniAbstract Liver receptor homologue 1 (LRH-1) plays important
roles in many physiological processes and embryogenesis. How-
ever, little is known about the developmental regulation of lrh-1
expression. We identiﬁed a novel transcript of mouse lrh-1 (mlrh-
1v2) from embryonic stem (ES) cells. mlrh-1v2 is expressed
throughout embryogenesis and in several adult tissues, while
the known transcript (mlrh-1v1) appears later during embryo-
genesis. mlrh-1v2 expression is directed by a new promoter which
displays a strong activity in ES cells. The generation of the new
transcript is conserved in rats. The identiﬁcation of novel mlrh-1
variant and promoter is critical for elucidating LRH-1 functions
in development and adult tissues.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Liver receptor homologue 1 (LRH-1), an orphan nuclear
receptor, is found predominantly in liver and pancreas, and
at lower levels in intestine and ovary [1–4], where it regulates
expression of many genes involved in diversiﬁed biological
processes including bile acid synthesis and cholesterol homeo-
stasis [5], sex hormone synthesis [4,6] as well as cell cycle con-
trol and neoplasm formation [7,8].
LRH-1 is also believed to regulate liver development, since it
modulates gene expression of a-fetoprotein and several liver-
enriched transcription factors such as HNF1a, HNF3b and
HNF4a which coordinate hepatic gene expression [9,10]. Actu-
ally, the function of LRH-1 in development goes beyond liver
organogenesis. Murine LRH-1 (mlrh-1) is expressed at the zy-
gotic stage of embryogenesis and homozygous mlrh-1 knock-
out embryos die around embryonic day 6.5 before the
initiation of liver development [11]. A recent study suggests
that mLRH-1 is required to maintain the expression of
OCT-4, an important regulator for the self-renewal of undiﬀer-Abbreviations: ES cells, embryonic stem cells; EST, expressed sequence
tag; LRH-1, liver receptor homologue 1; RACE, rapid ampliﬁcation of
cDNA ends; RT, reverse transcription
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doi:10.1016/j.febslet.2006.02.017entiated embryonic stem (ES) cells [12]. However, the previ-
ously identiﬁed promoters (P1) of both human and mouse
lrh-1 genes are only active in restricted cell types, regulated
mainly by hepatic and pancreatic transcriptional factors
[10,13,14]. Thus, regulation of lrh-1 expression in early
embryogenesis is an unresolved issue.
In this study, we identiﬁed a novel transcript of mlrh-1 (mlrh-
1v2) from ES cells. mlrh-1v2 1 is expressed throughout embryo-
genesis and in several adult tissues, while the known transcript
(mlrh-1v1) appears relatively later during embryogenesis. The
expression of mlrh-1v2 is controlled by a new promoter (P2)
which exhibits a strong activity in ES cells. The identiﬁcation
of the novel mlrh-1 transcript and promoter is critical for
elucidation of LRH-1 functions in development and adult
tissues.2. Materials and methods
2.1. Plasmids
The mlrh-1 P1 (713/+450) [10] and P2 (1329/+88) promoters
(transcription start site as 1) were ampliﬁed by PCR and inserted in
pGL3-Basic (Promega, Madison, WI). Reporter plasmids containing
P2 truncations were made similarly.
2.2. Animals
Balb/c mice and Wistar rats (Experimental animal center, Shanghai,
China) were handled in accordance to regulations approved by the
committee for animal tests of the Chinese Academy of Sciences.
2.3. RT-PCR
Total RNA was isolated with TRIzol reagent (Invitrogen Life Tech-
nologies) following the manufacturer’s instruction. Reverse transcrip-
tion (RT) was carried out using random priming method with
moloney murine leukemia virus reverse transcriptase (Promega).
PCR for the detection of mouse and rat lrh-1 transcripts was per-
formed with the following primers (Figs. 1, 2, and 5) (5 0 ﬁ 3 0):
pmf1, GGGTTACTGTAGTCTGAGGTTTC; pmr1 GGCTTCCGT-
CTCCACTTTGG; pmf2, AGCTCACCTGAGTCAATGATGG;
pmr2, GTTCTCCAGTAACCAGGAAG; pm2f1, CATCAGTT-
CAATACAACTAGATACC; pm2r1, GCTCTTCCAGATCTTCAT-
CATA; pr1f, CTAAGAATGTCTGCTAGTTCGA; pr1r, CAC-
ACACAGGACACAGCTCTTC; pr2f, GGCTTCAGATGTAGAT-
GATACG. For murine b-actin: pmaf, TGCTGTCCCTGT-
ATGCCTCTG; pmar, GAGCAACATAGCACAGCTTCTCT. For
rat b-actin: praf, ATTGTAACCAACTGGGACG; prar, TTGCCGA-
TAGTGATGACCT.1 The nucleotide sequence of mlrh-1v2 is available in DDBJ, EMBL
and GenBank databases under the Accession No. DQ133942.
blished by Elsevier B.V. All rights reserved.
Fig. 1. mlrh-1 expressed in ES cells is diﬀerent from mlrh-1v1. (A) Northern analysis of mlrh-1 expression in R1 ES cells. The mlrh-1 mRNA is
indicated by an arrow. A shorter RNA (about 3.6 kb) is also observed. (B) Reporter gene assays of the P1 promoter. The activities from transfections
with pGL3Basic are taken as 1, respectively. The means ± S.D. are presented. (C) RT-PCR analysis of mlrh-1 expression in ES cells. The fragments
spanning exons 1–2 (primers: pmf1/pmr1) and exons 6–7 (primers: pmf2/pmr2) were ampliﬁed, respectively using total RNA from liver and several
ES cell lines. b-Actin was ampliﬁed as an internal control. RT-, without reverse transcriptase.
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OPTICON 2 (MJ Research, Waltham, MA) with SYBR Green I
(Opentech, Shanghai, China). Primers pmf1 and pmr1 were used for
mlrh-1v1, and pm2f1 and pm2r1 for mlrh-1v2. PCR conditions were
40 cycles with denaturing at 94 C for 30 s, annealing at 52 C for
30 s and extension at 72 C for 30 s. A dissociation curve was gener-
ated in the range of 52–95 C. Relative mRNA expression levels were
calculated by DDCT analysis, using b-actinmRNA for internal normal-
ization. PCR was done in triplicate, and standard deviations represent-
ing experimental errors were calculated.
2.4. Northern analysis
Northern blot was performed as described previously [1]. 12 lg total
RNA of R1 cells was electrophoresed on 1% denaturing agarose gel
containing 0.7 M formaldehyde, transferred to Nytran membrane
(Schleicher & Schuell, Dassel, Germany) and hybridized with a 32P la-
beled probe corresponding to nt450–1500 of mlrh-1v1 cDNA.
2.5. Rapid ampliﬁcation of cDNA ends
5 0-Rapid ampliﬁcation of cDNA ends (RACE) was performed using
a 5 0-Full RACE Core Set (TaKaRa Biotech, Dalian, China). 1st strand
cDNA was primed with a 5 0 phosphorylated primer (rp1: 5 0-Pi-
GCTTCCGTCTCCAC-30) and synthesized by AMV reverse transcrip-
tase. After RNaseH digestion, cDNA was self-ligated by T4 RNAligase. A nested PCR was performed using this circular cDNA as tem-
plate (ﬁrst PCR, rpf1: 5 0-CCAAACGTGAGGAACAACTC-3 0 and
rpr1: 5 0-GATACTACGTTCTGAAGCCCGGGA-3 0; second PCR,
rpf2: 5 0-GCTGGGCTTCCGGACCGAC-30 and rpr2: 5 0-TCTGA-
AGCCCGGGAAGAGTC-3 0) and products were cloned and
sequenced.
2.6. Cell culture, transfections and reporter gene analysis
Mouse ES cell lines D3 (a gift from Prof. Z. Yao, Shanghai, China)
and E14.1 (kindly provided by Prof. P. Chambon, Strasburg, France)
were plated on mouse ﬁbroblast feeder cells and R1 (ATCC, Manas-
sas, VA) on 0.1% gelatin-coated dishes, grown in DMEM supple-
mented with 15% (v/v) fetal calf serum (Invitrogen Life
Technologies) and 1000 U/ml leukemia inhibitory factor (Chemicon,
Temecula, CA) at 37 C and 5% CO2. Transfections of R1 cells were
performed with Lipofectamine and Plus Reagent (Invitrogen Life
Technologies) following the product instruction. Human hepatocellu-
lar carcinoma Huh7 cells and mouse adrenocortical Y1 cells (ATCC)
were grown in DMEM supplemented with 10% (v/v) fetal calf serum
at 37 C and 5% CO2. Transfections were performed with the cal-
cium-phosphate precipitation method [15]. In general, cells were co-
transfected with 0.5 lg of a luciferase reporter and 0.3 lg of a b-galac-
tosidase expression plasmid pcDNA4-lacZ that served as an internal
control to normalize transfection eﬃciencies. Luciferase activities were
determined with Luciferase assay system (Promega) and b-galactosi-
Fig. 2. A novel transcriptmlrh-1v2 is expressed in ES cells. (A) Alignment of themlrh-1 EST BB652042 with the cDNA of mlrh-1v1. Small case letters
indicate the unaligned sequence in the EST. Splicing events are indicated with open triangles and exons are labeled above the sequence. The
translation initiation site of mlrh-1v1 and the predicted translation initiation site of mlrh-1v2 are shown in bold. (B) Veriﬁcation of mlrh-1v2 in ES cell
lines and mouse liver using RT-PCR with primers (pm2f1/pm2r1) indicated by arrow lines in (A). (C) Determine the transcription start site of mlrh-
1v2. The two bands were cloned and sequenced, and band a (lane 1) is found to be a dimer of band b. The complete sequence of exon A is shown with
the 29nt determined by 5 0-RACE underlined. (D) Diagram of the transcription of mlrh-1. The ﬁrst ATG of mlrh-1v2 is located in exon 3, which
corresponds to Met62 of mlrh-1v1. The P1 and P2 promoters are depicted by arrows. Open boxes: noncoding region in both mlrh-1 transcripts; gray
boxes: coding region appearing only in mlrh-1v1; black boxes: coding region present in both transcripts.
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method [15]. Luciferase activities of diﬀerent transfections were nor-
malized by b-galactosidase activities. Each transfection was performed
in duplicate 35 mm dishes and repeated at least three times.3. Results and discussion
3.1. A novel mlrh-1 transcript is expressed in ES cells
Despite its essential function, little is known about the regu-
lation of lrh-1 gene expression in early embryogenesis. We used
ES cells as a model system to investigate mlrh-1 expression in
early embryogenesis. The expression of mlrh-1 in R1 ES cells
was demonstrated by Northern analysis (Fig. 1A). Transfec-
tions and reporter gene assays were followed to examinewhether mlrh-1 expression in R1 cells is driven by the P1 pro-
moter. As shown in Fig. 1B, the P1 promoter was inactive in
R1 cells, in contrast to its high activity in human hepatocellu-
lar carcinoma Huh7 cells. The inactivity of P1 in R1 cells could
be due to either the absence of unknown ES-speciﬁc regulatory
elements in tested promoter region or the possibility that P1 is
not responsible for mlrh-1 expression in ES cells. In the latter
case, the mlrh-1 transcript in ES cells would likely diﬀer from
what was previously identiﬁed (mlrh-1v1) in several adult tis-
sues, especially in the 5 0 terminus. To explore this possibility,
RNA from adult liver and several ES cell lines were subjected
to RT-PCR. A fragment spanning exons 1 and 2 was only
ampliﬁed from liver RNA whereas that spanning exons 6
and 7 was ampliﬁed from both liver and ES cell RNAs
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transcript (mlrh-1v2) and a unknown regulatory mechanism of
mlrh-1 gene expression in ES cells.
By analyzing expressed sequence tags (ESTs) of mlrh-1,
we found an EST (dbEST No. BB652042) containing a
108nt 5 0 terminal fragment that does not match exon 1 ofFig. 3. P2 promoter displays a strong activity in R1 ES cells. (A) Diagram of P
respectively. (B) P2 exhibits a strong activity in R1 cells. Huh7, Y1 and R1 ce
empty vector pGL3Basic, respectively. (C) The element between 260 and 
were transfected with various P2 truncations or pGL3Basic. Luciferase acti
activities from transfections with pGL3Basic are taken as 1, respectively. Th
Fig. 4. Embryonic and tissue expression patterns of mlrh-1 transcripts. (A) R
C: plasmid templates were used as positive controls. b-Actin was ampliﬁed as
quantitative RT-PCR of each transcript with total RNAs from adult mouse t
The ampliﬁcation eﬃciencies of mlrh-1v1 and mlrh-1v2 using cloned cDNAs a
Black and gray bars represent relative abundance of mlrh-1v1 and mlrh-1v2mlrh-1 whereas the remaining sequence aligns to the second
and downstream exons (Fig. 2A). Interestingly, this EST
originated from ES cells. Indeed, RT-PCR conﬁrmed the
presence of the 108nt fragment in mlrh-1v2 transcript and
also indicate the contemporary expression of both mlrh-1
transcripts in liver (Fig. 2B). Subsequently, inverted PCR-1 and P2 promoter reporters. The transcription start sites are set as +1,
lls were transfected with the 1.4 kb P2 reporter, the P1 reporter and the
236 is important for the ES-speciﬁc activity of P2. Huh7 and R1 cells
vities were assayed and normalized by b-galactosidase activities. The
e means ± S.D. are presented.
T-PCR of each transcript with total RNAs from mouse embryos. Lane
an internal control. RT-, without reverse transcriptase. (B) Real-time
issues (liver, pancreas, smooth muscle, heart, spleen, ovary and testis).
s templates are estimated to be similar (<5% diﬀerence after 30 cycles).
to b-actin levels, respectively.
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tion start site (TSS) of mlrh-1v2 which mapped to 29nt up-
stream of the 5 0 terminus of the EST (Fig. 2C). Alignment
with mlrh-1 gene revealed that the 5 0 137nt sequence of
mlrh-1v2 falls within intron 1 and represents a new exon
(exon A). The full-length cDNA for mlrh-1v2 was obtained
by RT-PCR (data not shown). The ﬁrst ATG that can be
used for translation initiation is within exon 3 (Fig. 2D).
The predicted mLRH-1v2 protein is composed of 499 ami-
no acids and would lack the N-terminal 61 residues of
mLRH-1v1, only aﬀects the integrity of the A/B domain
but not other domains including the DNA binding domain
and the ligand binding domain, suggesting the two mLRH-1
proteins might be functionally redundant. However, our re-
sults do not rule out the possibility that each protein might
be selectively used in regulating the expression of certain
target genes.Fig. 5. Conserved generation of the lrh-1v2 transcript in rats. (A) A region sim
be detected by RT-PCR with a speciﬁc primer based on the putative rlrh-1 ex
Diagram of the predicted expression of rlrh-1 transcripts. rlrh-1v3 is an alterna
3. However, the predicted proteins translated from rlrh-1v2 and rlrh-1v3 are3.2. mlrh-1v2 expression is controlled by a new promoter
The diﬀerential expression of mlrh-1 transcripts suggest that
they are regulated by diﬀerent promoters. A 1.4 kb fragment
(P2) upstream of exon A was ampliﬁed (Fig. 3A) and the pro-
moter activity was examined in R1 cells as well as in cell lines
such as Huh7 and Y1, and was compared with that of P1. P2
displayed a very strong activity in R1 cells but much lower
activities in Huh7 and Y1 cells (Fig. 3B). Serial 5 0 deletions
were made to pin down the region of P2 responsible for the
ES-speciﬁc activity (Fig. 3A). As shown in Fig. 3C, although
they were comparably low in Huh7 cells, the activities of var-
ious P2 truncations diﬀer greatly in R1 cells, suggesting the
existence of ES-speciﬁc cis-elements. A short region between
260 and 236 is particularly important for the high activity
of P2 in R1 cells. Bioinformatic analysis via TESS (http://
www.cbil.upenn.edu/tess) suggests that a few factors such as
C/EBPa, C/EBPb, HNF-3, SRY might bind to this region.ilar to mouse exon A is found in rlrh-1 gene intron 1. (B) rlrh-1v2 could
on A during rat embryogenesis. RT-, without reverse transcriptase. (C)
tively spliced variant of rlrh-1v2 without the ﬁrst 45 nucleotides of exon
identical. The putative P1 and P2 promoters are depicted by arrows.
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we did not observe obvious transactivation of P2 by HNF3a,
HNF3b, HNF3c, and C/EBPa, (data not shown). Undoubt-
edly, identiﬁcation of the factor(s) regulating the embryonic-
and tissue-speciﬁc P2 activities would help elucidate new
biological functions of mLRH-1. The regulation of the P2
promoter warrants further study.3.3. Expression of mlrh-1 transcripts during embryogenesis and
in adult tissues
The expression ofmlrh-1v2might reﬂect diﬀerent requirements
at distinct developmental stages and in diﬀerent tissue types. To
investigate the expression of each transcript in embryogenesis,
mouse embryos were analyzed by RT-PCR. mlrh-1v2 is ex-
pressed throughout embryonic development whereas mlrh-1v1
is detectable only from day 10.5 on (Fig. 4A). Therefore, the
essential function ofmlrh-1 in early embryogenesis is contributed
mainly by mlrh-1v2 rather than mlrh-1v1 and the embryonic
lethality around day 6.5 of homozygous knockout mouse is
due to the loss of mlrh-1v2 expression.
In adult mice, mlrh-1v1 is highly expressed in liver and pan-
creas as previously reported, while mlrh-1v2 is moderately ex-
pressed in these tissues. Moderate expression of mlrh-1v1
accompanied by lower level mlrh-1v2 expression was observed
in smooth muscle. Only mlrh-1v2 was detected in ovary where
mLRH-1 regulates the expression of aromatase gene and may
be related to breast cancer development [6,16]. Similar expres-
sion patterns were observed in heart and testis (Fig. 4B). The
results indicate that tissue distribution of mlrh-1 transcripts
in adult mice are partially overlapping, but with important
temporal and spatial diﬀerences. Identiﬁcation of mlrh-1v2
thus sheds new light on the functions of mLRH-1 during
embryogenesis and in many tissues.3.4. Conserved expression of the novel transcript in rats
A region homologous to mlrh-1 gene exon A was also iden-
tiﬁed in the intron 1 of rlrh-1 gene (Fig. 5A). Subsequently,
RT-PCR was performed using an upstream primer speciﬁc
to this region. As shown in Fig. 5B, an mlrh-1v2-like transcript
was detected from rat embryos at day 7.5 and 13.5, while the
expression of rlrh-1v1 was not observed at day 7.5, which is
consistent with the expression pattern of their mouse counter-
parts. It is noteworthy that there is one more rlrh-1 transcript
(rlrh-1v3) expressed during rat embryogenesis. Sequence anal-
ysis of the cloned fragment revealed that rlrh-1v3 is the product
of alternative splicing which joins exon 2 to an internal accep-
tor site in exon 3 (Fig. 5C). Taken together, these data indicate
that the generation of mlrh-1v2-like transcript is conserved in
mice and rats.
Alternative promoter usage has also been observed in the
FF1 gene which encodes the zebraﬁsh orthologue of mLRH-
1 [17]. Together with our ﬁndings, an important question
arises: does human LRH-1 gene employ a similar regulatory
mechanism to produce variant(s) during embryogenesis and
in some adult tissues? We performed an alignment of the ﬁrst
introns of mlrh-1 and hLRH-1 genes and found a region show-
ing a low homology to mouse P2 in hLRH-1 intron 1. How-
ever, no promoter activity of the suspected region was
observed in R1 ES cells (data not shown). It would be interest-
ing to test this fragment for promoter activity in human EScells. On the other hand, hLRH-1 may possess a second
promoter dissimilar to rodent lrh-1 P2. Given the importance
of mLRH-1 in development, regulation of hLRH-1 expression
in human embryo development warrants further
investigation.
Acknowledgements: The authors are grateful to Prof. Zhen Yao, Pierre
Chambon and Xiao-qian Cong for providing the ES cell lines. This
work was supported by NNSF of China (30393112), MOST
(2005CB522400), CAS (KSCX2-SW-208), and Shanghai Science and
Technology Committee (04DZ14006).References
[1] Li, M., Xie, Y.H., Kong, Y.Y., Wu, X., Zhu, L. and Wang, Y.
(1998) Cloning and characterization of a novel human hepatocyte
transcription factor, hB1F, which binds and activates enhancer II
of hepatitis B virus. J. Biol. Chem. 273, 29022–29031.
[2] Nitta, M., Ku, S., Brown, C., Okamoto, A.Y. and Shan, B. (1999)
CPF: an orphan nuclear receptor that regulates liver-speciﬁc
expression of the human cholesterol 7a-hydroxylase gene. Proc.
Natl. Acad. Sci. USA 96, 6660–6665.
[3] Rausa, F.M., Galarneau, L., Belanger, L. and Costa, R.H. (1999)
The nuclear receptor fetoprotein transcription factor is
coexpressed with its target gene HNF-3b in the developing
murine liver, intestine and pancreas. Mech. Dev. 89, 185–188.
[4] Falender, A.E., Lanz, R., Malenfant, D., Belanger, L. and
Richards, J.S. (2003) Diﬀerential expression of steroidogenic
factor-1 and FTF/LRH-1 in the rodent ovary. Endocrinology
144, 3598–3610.
[5] Fayard, E., Auwerx, J. and Schoonjans, K. (2004) LRH-1: an
orphan nuclear receptor involved in development, metabolism
and steroidogenesis. Trends Cell Biol. 14 (5), 250–260.
[6] Clyne, C.D., Speed, C.J., Zhou, J. and Simpson, E.R. (2002) Liver
receptor homologue-1 (LRH-1) regulates expression of aromatase
in preadipocytes. J. Biol. Chem. 277, 20591–20597.
[7] Botrugno, O.A., Fayard, E., Annicotte, J.S., Haby, C., Brennan,
T., Wendling, O., Tanaka, T., Kodama, T., Thomas, W., Auwerx,
J. and Schoonjans, K. (2004) Synergy between LRH-1 and b-
catenin induces G1 cyclin-mediated cell proliferation. Mol. Cell
15, 499–509.
[8] Schoonjans, K., Dubuquoy, L., Mebis, J., Fayard, E., Wendling,
O., Haby, C., Geboes, K. and Auwerx, J. (2005) Liver receptor
homolog 1 contributes to intestinal tumor formation through
eﬀects on cell cycle and inﬂammation. Proc. Natl. Acad. Sci. USA
102, 2058–2062.
[9] Galarneau, L., Pare, J.F., Allard, D., Hamel, D., Levesque, L.,
Tugwood, J.D., Green, S. and Belanger, L. (1996) The alpha1-
fetoprotein locus is activated by a nuclear receptor of the
Drosophila FTZ-F1 family. Mol. Cell. Biol. 16, 3853–
3865.
[10] Pare, J.F., Roy, S., Galarneau, L. and Belanger, L. (2001) The
mouse fetoprotein transcription factor (FTF) gene promoter is
regulated by three GATA elements with tandem E box and Nkx
motifs, and FTF in turn activates the hnf3beta, hnf4alpha, and
hnf1alpha gene promoters. J. Biol. Chem. 276, 13136–13144.
[11] Pare, J.F., Malenfant, D., Courtemanche, C., Jacob-Wagner, M.,
Roy, S., Allard, D. and Belanger, L. (2004) The fetoprotein
transcription factor (FTF) gene is essential to embryogenesis and
cholesterol homeostasis and is regulated by a DR4 element. J.
Biol. Chem. 279, 21206–21216.
[12] Gu, P., Goodwin, B., Chung, A.C., Xu, X., Wheeler, D.A., Price,
R.R., Galardi, C., Peng, L., Latour, A.M., Koller, B.H., Gossen,
J., Kliewer, S.A. and Cooney, A.J. (2005) Orphan nuclear
receptor LRH-1 is required to maintain Oct4 expression at the
epiblast stage of embryonic development. Mol. Cell. Biol. 25,
3492–3505.
[13] Annicotte, J.S., Fayard, E., Swift, G.H., Selander, L., Edlund, H.,
Tanaka, T., Kodama, T., Schoonjans, K. and Auwerx, J. (2003)
Pancreatic-duodenal homeobox 1 regulates expression of liver
receptor homolog 1 during pancreas development. Mol. Cell.
Biol. 23, 6713–6724.
1708 D. Gao et al. / FEBS Letters 580 (2006) 1702–1708[14] Zhang, C.K., Lin, W., Cai, Y.N., Xu, P.L., Dong, H., Li, M.,
Kong, Y.Y., Fu, G., Xie, Y.H., Huang, G.M. and Wang, Y.
(2001) Characterization of the genomic structure and tissue-
speciﬁc promoter of the human nuclear receptor NR5A2 (hB1F)
gene. Gene 273, 239–249.
[15] Sambrook, J. and Russell, D.W. (2001) Molecular Cloning: A
Laboratory Manual, 3rd edn, Cold Spring Harbor Laboratory
Press, New York.[16] Zhou, J., Suzuki, T., Kovacic, A., Saito, R., Miki, Y., Ishida, T.,
Moriya, T., Simpson, E.R., Sasano, H. and Clyne, C.D. (2005)
Interactions between prostaglandin E(2), liver receptor homo-
logue-1, and aromatase in breast cancer. Cancer Res. 65, 657–663.
[17] Lin, W., Wang, H.W., Sum, C., Liu, D., Hew, C.L. and Chung, B.
(2000) Zebraﬁsh ftz-f1 gene has two promoters, is alternatively
spliced, and is expressed in digestive organs. Biochem. J. 348, 439–
446.
